Hallucinating Long After the Trip is Over: HPPD – Part 2
Potential causes, risks, and ongoing research for Hallucinogen Persisting Perception Disorder (HPPD).
Health
Hallucinating Long After the Trip is Over: HPPD – Part 1
An overview of the symptoms of Hallucinogen Persisting Perception Disorder (HPPD), how it differs from flashbacks, and how common it might be.
Tackling Trauma with Pharmahuasca and DMT
Psychedelics may hold the key to a novel PTSD treatment.
Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
More than half a century since its development, the head-twitch response assay still plays a prominent role in psychedelic research.
MDMA-Assisted Psychotherapy for PTSD: Interviewing Dr. Rachel Yehuda
Dr. Rachel Yehuda shares details about an ongoing clinical trial involving MDMA-assisted psychotherapy to treat post-traumatic stress disorder in veterans.
Psychedelics and Substance Use Disorder: 4000 BCE to Present Day
The therapeutic uses of psychedelics were discovered over 6,000 years ago, but recent scientific exploration brings them to the mainstream.
Ibogaine and Cardiac Arrhythmia: The Heart of the Matter
Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
Psychedelics and Mysticism: The Debate Continues
New perspectives on whether mystical experiences have a place in psychedelic science.
How Likely Are Bad Trips and Flashbacks from LSD?
Researchers give us some new data on LSD’s chances of causing bad trips, flashbacks, and other adverse effects.
The Therapeutic Effects of Psychedelics: 2A or Not 2A?-Part 2
Some studies reveal that serotonin 2A receptor activation may not be necessary for the potential therapeutic effects of psychedelics.